aidsmap: Kaposi sarcoma claims lives of South Africans with HIV, despite the ART rollout

Back to the "HIV and Co-Infections News" list

aidsmap news story

Patients with Kaposi sarcoma (KS) in South Africa are presenting late to healthcare facilities and have an overall poor prognosis, despite the decade-long rollout of antiretroviral therapy, according to a new study.

KS is a cancer caused by the human herpes virus 8 (HHV-8) and usually appears as lesions on the skin or on mucosal surfaces, like inside the mouth or in the genital area.

While it is considered rare in the general population, it is more common in people with HIV, particularly in African countries. In South Africa, it is the second most common cancer in people living with HIV.

Read the full news story here.

 

Source : aidsmap

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.